OncoImmunology, Volume 2, Issue 8 (2013)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

OncoImmunology, Volume 2, Issue 8 (2013)

See all volumes and issues
Vol 13, 2024 Vol 12, 2023 Vol 11, 2022 Vol 10, 2021 Vol 9, 2020 Vol 8, 2019 Vol 7, 2018 Vol 6, 2017 Vol 5, 2016 Vol 4, 2015 Vol 3, 2014 Volume 2, 2013 Vol 1, 2012
Download citations Download PDFs

Editorial

Editorial
New immunotherapeutic paradigms for castration-resistant prostate cancer
Lorenzo Galluzzi
Article: e26084
Published online: 07 Aug 2013
First Page PreviewforNew immunotherapeutic paradigms for castration-resistant prostate cancer | Full Text | References | PDF (188.7 KB)
  • 696 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
James P Stevenson, Hedy L Kindler, Emmanouil Papasavvas, Jing Sun, Mona Jacobs-Small, Jennifer Hull, Daniel Schwed, Anjana Ranganathan, Kheng Newick, Daniel F Heitjan, Corey J Langer, John M McPherson, Luis J Montaner & Steven M Albelda
Article: e26218
Published online: 27 Aug 2013
AbstractforImmunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients | Full Text | References | PDF (458.4 KB) | Supplemental
  • 2380 Views
  • 63 CrossRef citations
  • 0Altmetric
Open Access
Article
GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients
Lynda Thyer, Emma Ward, Rodney Smith, Jacopo JV Branca, Gabriele Morucci, Massimo Gulisano, David Noakes, Robert Eslinger & Stefania Pacini
Article: e25769
Published online: 29 Jul 2013
AbstractforGC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients | Full Text | References | PDF (239.8 KB)
  • 2750 Views
  • 13 CrossRef citations
  • 0Altmetric
Open Access
Article
Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes
Patrick Guirnalda, Laurence Wood, Radhika Goenka, Joel Crespo & Yvonne Paterson
Article: e25752
Published online: 23 Jul 2013
AbstractforInterferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes | Full Text | References | PDF (540.3 KB) | Supplemental
  • 1411 Views
  • 28 CrossRef citations
  • 0Altmetric
Open Access
Article
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+ T-cell responses to anticancer vaccines
Byram W Bridle, Derek Clouthier, Liang Zhang, Jonathan Pol, Lan Chen, Brian D Lichty, Jonathan L Bramson & Yonghong Wan
Article: e26013
Published online: 27 Aug 2013
AbstractforOncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+ T-cell responses to anticancer vaccines | Full Text | References | PDF (653.5 KB)
  • 1265 Views
  • 46 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Trial Watch
Toll-like receptor agonists for cancer therapy
Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jerome Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi
Article: e25238
Published online: 10 Jun 2013
AbstractforTrial Watch | Full Text | References | PDF (271.4 KB)
  • 3178 Views
  • 115 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
Christel Devaud, Liza B John, Jennifer A Westwood, Phillip K Darcy & Michael H Kershaw
Article: e25961
Published online: 22 Aug 2013
AbstractforImmune modulation of the tumor microenvironment for enhancing cancer immunotherapy | Full Text | References | PDF (752.7 KB)
  • 3855 Views
  • 145 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Immunological monitoring of anticancer vaccines in clinical trials
Chizuru Ogi & Atsushi Aruga
Article: e26012
Published online: 23 Aug 2013
AbstractforImmunological monitoring of anticancer vaccines in clinical trials | Full Text | References | PDF (245.7 KB)
  • 882 Views
  • 32 CrossRef citations
  • 0Altmetric
Open Access

Point of View

Biological insights into BRAFV600 mutations in melanoma patient
Not mere therapeutic targets
Giuseppina Improta, Giuseppe Pelosi, Elena Tamborini, Marco Donia, Mario Santinami, Filippo de Braud & Filippo Fraggetta
Article: e25594
Published online: 03 Jul 2013
AbstractforBiological insights into BRAFV600 mutations in melanoma patient | Full Text | References | PDF (347.5 KB)
  • 586 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses
Denarda Dangaj & Nathalie Scholler
Article: e25913
Published online: 31 Jul 2013
AbstractforBlocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses | Full Text | References | PDF (264.9 KB)
  • 1291 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access

Author's View

Function-first antibody discovery
Embracing the unpredictable biology of antibodies
Björn Frendéus
Article: e25047
Published online: 20 May 2013
AbstractforFunction-first antibody discovery | Full Text | References | PDF (346.1 KB)
  • 725 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Combination of adoptive cell transfer, anti-PD-L1 and anti-LAG-3 antibodies for the treatment of recurrent tumors
Better with more
Stephen R Goding, Kyle A Wilson & Paul Andrew Antony
Article: e25050
Published online: 20 May 2013
AbstractforCombination of adoptive cell transfer, anti-PD-L1 and anti-LAG-3 antibodies for the treatment of recurrent tumors | Full Text | References | PDF (296.3 KB)
  • 1708 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Myeloid-derived suppressor cells as a Trojan horse
A cellular vehicle for the delivery of oncolytic viruses
Ping-Ying Pan, Hui-ming Chen & Shu-Hsia Chen
Article: e25083
Published online: 28 May 2013
AbstractforMyeloid-derived suppressor cells as a Trojan horse | Full Text | References | PDF (289 KB)
  • 624 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma
Roberta Rosa, Vincenzo Damiano, Luigi Formisano, Lucia Nappi, Roberta Marciano, Bianca Maria Veneziani, Sabino De Placido & Roberto Bianco
Article: e25123
Published online: 28 May 2013
AbstractforCombination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma | Full Text | References | PDF (267.2 KB)
  • 385 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
MicroRNAs as novel immunotherapeutics
Amy B Heimberger, Mark Gilbert, Ganesh Rao & Jun Wei
Article: e25124
Published online: 28 May 2013
AbstractforMicroRNAs as novel immunotherapeutics | Full Text | References | PDF (213.4 KB)
  • 534 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Novel function of STAT1 in breast cancer
Ming Zhang
Article: e25125
Published online: 28 May 2013
AbstractforNovel function of STAT1 in breast cancer | Full Text | References | PDF (155.6 KB)
  • 576 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
How the devil facial tumor disease escapes host immune responses
Hannah V Siddle & Jim Kaufman
Article: e25235
Published online: 10 Jun 2013
AbstractforHow the devil facial tumor disease escapes host immune responses | Full Text | References | PDF (306.3 KB)
  • 1670 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer
Magali Terme, Eric Tartour & Julien Taieb
Article: e25156
Published online: 10 Jun 2013
AbstractforVEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer | Full Text | References | PDF (230.9 KB)
  • 1142 Views
  • 26 CrossRef citations
  • 0Altmetric
Open Access
Cyclooxygenase-2
Steering force of myeloid-derived suppressor cells in cancer?
Yumeng Mao, Isabel Poschke & Rolf Kiessling
Article: e25157
Published online: 10 Jun 2013
AbstractforCyclooxygenase-2 | Full Text | References | PDF (206 KB)
  • 391 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Immunological consequences of selective BRAF inhibitors in malignant melanoma
Neutralization of myeloid-derived suppressor cells
Bastian Schilling & Annette Paschen
Article: e25218
Published online: 10 Jun 2013
AbstractforImmunological consequences of selective BRAF inhibitors in malignant melanoma | Full Text | References | PDF (268.3 KB)
  • 632 Views
  • 33 CrossRef citations
  • 0Altmetric
Open Access
HDAC inhibitors and their potential applications to glioblastoma therapy
Eleni Adamopoulou & Ulrike Naumann
Article: e25219
Published online: 10 Jun 2013
AbstractforHDAC inhibitors and their potential applications to glioblastoma therapy | Full Text | References | PDF (452.3 KB)
  • 988 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access
Arming NK cells with enhanced antitumor activity
CARs and beyond
Pranav Oberoi & Winfried S Wels
Article: e25220
Published online: 10 Jun 2013
AbstractforArming NK cells with enhanced antitumor activity | Full Text | References | PDF (450 KB)
  • 1172 Views
  • 22 CrossRef citations
  • 0Altmetric
Open Access
Immunological profiling as a means to invigorate personalized cancer therapy
Joost PJJ Hegmans & Joachim GJV Aerts
Article: e25236
Published online: 10 Jun 2013
AbstractforImmunological profiling as a means to invigorate personalized cancer therapy | Full Text | References | PDF (313 KB)
  • 427 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
The many flavors of tumor-associated B cells
Per Marits, Ali A Zirakzadeh, Amir Sherif & Ola Winqvist
Article: e25237
Published online: 10 Jun 2013
AbstractforThe many flavors of tumor-associated B cells | Full Text | References | PDF (271.6 KB)
  • 529 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?
Alexander Swarbrick, Simon R Junankar & Marcel Batten
Article: e25409
Published online: 01 Jul 2013
AbstractforCould the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy? | Full Text | References | PDF (219.4 KB)
  • 519 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Microsatellite instability in hematological malignancies
Hypermutation vs. immune control—who is challenging who?
Claudia Maletzki, Saskia Stier & Michael Linnebacher
Article: e25419
Published online: 01 Jul 2013
AbstractforMicrosatellite instability in hematological malignancies | Full Text | References | PDF (441.5 KB)
  • 727 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation
Shigeo Koido, Sadamu Homma, Masato Okamoto, Yoshihisa Namiki, Shin Kan, Kazuki Takakura, Mikio Kajihara, Kan Uchiyama, Eiich Hara, Toshifumi Ohkusa, Jianlin Gong & Hisao Tajiri
Article: e25375
Published online: 01 Jul 2013
AbstractforImproved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation | Full Text | References | PDF (279.4 KB)
  • 422 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Peripheral T-cell tolerance in hosts with acute myeloid leukemia
Xiufen Chen, Douglas E Kline & Justin Kline
Article: e25445
Published online: 01 Jul 2013
AbstractforPeripheral T-cell tolerance in hosts with acute myeloid leukemia | Full Text | References | PDF (217.8 KB)
  • 666 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Recruitment of γδ T lymphocytes to tumors
A new role for the pleiotropic chemokine CCL2
Telma Lança & Bruno Silva-Santos
Article: e25461
Published online: 01 Jul 2013
AbstractforRecruitment of γδ T lymphocytes to tumors | Full Text | References | PDF (206.3 KB)
  • 556 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Humanizing mice for the identification of novel anticancer lipids targeting iNKT cells
Xiangshu Wen, Ran Xiong, Zhengxi Dai, Seil Kim, Agnieszka Lawrenczyk & Weiming Yuan
Article: e25475
Published online: 01 Jul 2013
AbstractforHumanizing mice for the identification of novel anticancer lipids targeting iNKT cells | Full Text | References | PDF (343.3 KB)
  • 501 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
The dual role of IRF8 in cancer immunosurveillance
Giovanna Schiavoni, Lucia Gabriele & Fabrizio Mattei
Article: e25476
Published online: 01 Jul 2013
AbstractforThe dual role of IRF8 in cancer immunosurveillance | Full Text | References | PDF (427.2 KB)
  • 802 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Immunogenic oncolysis by tigilanol tiglate
Jonathan G. Pol et al.
Comment | Published online: 27 May 2024
Open Access
Clinically relevant GABARAP deficiency abrogates bortezomib-induced immunogenic cell death in multiple myeloma
Liwei Zhao et al.
Comment | Published online: 27 May 2024
Open Access
CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival
Siyue Nie et al.
Article | Published online: 24 May 2024
Open Access
Peripheral CX3CR1+ T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer
Congcong Li et al.
Article | Published online: 22 May 2024
Open Access
View all latest articles